CCR9 signaling in dendritic cells drives the differentiation of Foxp3+ Tregs and suppresses the allergic IgE response in the gut
Open Access
- 22 November 2019
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 50 (3) , 404-417
Abstract
The chemokine receptor CCR9 and its only known ligand CCL25 play an important role in gut inflammation and autoimmune colitis. The function of CCR9‐CCL25 in the migration of immune cells is well characterized. However, its role in the immune cell differentiation is mostly not known. Using dextran sodium sulfate (DSS)‐induced gut inflammation model, we showed that CCR9+ dendritic cells (DCs) specifically CD11b−CD103+ DCs were significantly increased in the gut‐associated lymphoid tissues (GALT) compared to control mice. These CCR9+ DCs express lower MHC II and CD86 molecules and had regulatory surface markers (FasL and latency‐associated peptide, LAP) in the GALT. In the presence of CCL25, CCR9+ DCs promoted in vitro differentiation of Foxp3+ regulatory CD4+ T cells (Tregs). CCL25‐induced differentiation of Tregs was due to intrinsic signaling in the DCs but not through CD4+ T cells, which was driven by the production of thymic stromal lymphopoietin (TSLP) and not IL‐10. Furthermore, adoptive transfer of CCR9+ DCs in C57BL/6 mice promoted Tregs but reduced the Th17 cells in the GALT, and also suppressed the OVA‐specific gut‐allergic response. Our results suggest CCR9+ DCs have a regulatory function and may provide a new cellular therapeutic strategy to control gut inflammation and allergic immune reaction.Keywords
Funding Information
- Department of Science and Technology, Ministry of Science and Technology, India
- Anusandhan National Research Foundation (PDF/2015/000792)
- Department of Biotechnology, Ministry of Science and Technology, India (BT/PR14156/BRB/10/1515/2016, BT/PR15533/MED/30/1616/2015)
This publication has 51 references indexed in Scilit:
- IRF4 Transcription Factor-Dependent CD11b+ Dendritic Cells in Human and Mouse Control Mucosal IL-17 Cytokine ResponsesImmunity, 2013
- A Randomized Controlled Trial of the Efficacy and Safety of CCX282-B, an Orally-Administered Blocker of Chemokine Receptor CCR9, for Patients with Crohn’s DiseasePLOS ONE, 2013
- Dendritic cells produce TSLP that limits the differentiation of Th17 cells, fosters Treg development, and protects against colitisMucosal Immunology, 2012
- Functions of thymic stromal lymphopoietin in immunity and diseaseImmunologic Research, 2012
- Gut-Tropic T Cells That Express Integrin α4β7 and CCR9 Are Required for Induction of Oral Immune Tolerance in MiceGastroenterology, 2011
- CCL25/CCR9 Interactions Regulate Large Intestinal Inflammation in a Murine Model of Acute ColitisPLOS ONE, 2011
- Intestinal Dendritic Cells2010
- Inverse relationship between dendritic cell CCR9 expression and maturation stateImmunology, 2009
- Dendritic cells in intestinal immune regulationNature Reviews Immunology, 2008
- CCR9 is a homing receptor for plasmacytoid dendritic cells to the small intestineProceedings of the National Academy of Sciences, 2007